Dec 15, 2025
Milestone Pharmaceuticals (MIST) Stock: Wild Price Swings Follow FDA Approval Decision
Milestone Pharmaceuticals stock: Trading volatility surges after FDA approval of CARDAMYST as investors scrutinize commercial strategy and launch plans.
The post Milestone Pharmaceuticals (MIST) Stock: Wild Price Swings Follow FDA Approval Decision appeared first on Blockonomi.
Source: Blockonomi →Related News
- 6 days ago
Bitcoin (BTC) Price: Bitfinex Long Positions Surge to 28-Month Peak — Historical...
- 1 week ago
How a $100 Oil Shock Is Putting Bitcoin’s Digital Gold Status to the Test
- 1 week ago
Dogecoin’s Repeating Cycle Structure Points to Potential Markup Phase Ahead
- 1 week ago
S&P 500 Drops for Fifth Week as Crash Warnings Rise Amid Iran War Fears
- 1 week ago
StarkWare Co-Founder Defends ZK Technology Amid Canton, Ethereum, and Solana Riv...